Metropolitan Life Insurance Company (MetLife)’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-11,668
| Closed | -$3.09M | – | 2596 |
|
|
2021
Q4 | $3.09M | Sell |
11,668
-171
| -1% | -$46.1K | 0.04% | 351 |
|
|
2021
Q3 | $3.42M | Sell |
11,839
-390
| -3% | -$100K | 0.05% | 302 |
|
|
2021
Q2 | $2.44M | Sell |
12,229
-316
| -3% | -$61.3K | 0.03% | 432 |
|
|
2021
Q1 | $2.44M | Buy |
12,545
+533
| +4% | +$109K | 0.04% | 427 |
|
|
2020
Q4 | $2.3M | Sell |
12,012
-42
| -0.3% | -$7.64K | 0.03% | 418 |
|
|
2020
Q3 | $1.78M | Sell |
12,054
-262
| -2% | -$37.5K | 0.03% | 460 |
|
|
2020
Q2 | $1.52M | Sell |
12,316
-14,658
| -54% | -$1.72M | 0.03% | 514 |
|
|
2020
Q1 | $2.6M | Sell |
26,974
-1,112
| -4% | -$107K | 0.05% | 301 |
|
|
2019
Q4 | $2.6M | Sell |
28,086
-121
| -0.4% | -$10.2K | 0.04% | 408 |
|
|
2019
Q3 | $2.16M | Buy |
28,207
+15,106
| +115% | +$1.32M | 0.04% | 471 |
|
|
2019
Q2 | $1.13M | Buy |
13,101
+536
| +4% | +$36.5K | 0.02% | 829 |
|
|
2019
Q1 | $742K | Hold |
12,565
| – | – | 0.01% | 1050 |
|
|
2018
Q4 | $663K | Hold |
12,565
| – | – | 0.01% | 1036 |
|
|
2018
Q3 | $697K | Hold |
12,565
| – | – | 0.01% | 1144 |
|
|
2018
Q2 | $591K | Buy |
12,565
+307
| +3% | +$12.6K | 0.01% | 1198 |
|
|
2018
Q1 | $443K | Hold |
12,258
| – | – | 0.01% | 1359 |
|
|
2017
Q4 | $445K | Sell |
12,258
-12,974
| -51% | -$470K | 0.01% | 1367 |
|
|
2017
Q3 | $967K | Buy |
25,232
+2,316
| +10% | +$97.1K | 0.01% | 1274 |
|
|
2017
Q2 | $950K | Hold |
22,916
| – | – | 0.01% | 1270 |
|
|
2017
Q1 | $807K | Sell |
22,916
-984
| -4% | -$31.2K | 0.01% | 1346 |
|
|
2016
Q4 | $737K | Hold |
23,900
| – | – | 0.01% | 1479 |
|
|
2016
Q3 | $722K | Sell |
23,900
-449
| -2% | -$13.6K | 0.01% | 1468 |
|
|
2016
Q2 | $666K | Buy |
24,349
+576
| +2% | +$14.7K | ﹤0.01% | 1514 |
|
|
2016
Q1 | $638K | Hold |
23,773
| – | – | ﹤0.01% | 1435 |
|
|
2015
Q4 | $673K | Hold |
23,773
| – | – | 0.01% | 1432 |
|
|
2015
Q3 | $662K | Hold |
23,773
| – | – | ﹤0.01% | 1443 |
|
|
2015
Q2 | $981K | Sell |
23,773
-398
| -2% | -$14.6K | 0.01% | 1296 |
|
|
2015
Q1 | $734K | Sell |
24,171
-4,018
| -14% | -$104K | 0.01% | 1370 |
|
|
2014
Q4 | $558K | Hold |
28,189
| – | – | ﹤0.01% | 1686 |
|
|
2014
Q3 | $561K | Hold |
28,189
| – | – | ﹤0.01% | 1646 |
|
|
2014
Q2 | $642K | Hold |
28,189
| – | – | ﹤0.01% | 1647 |
|
|
2014
Q1 | $363K | Hold |
28,189
| – | – | ﹤0.01% | 2027 |
|
|
2013
Q4 | $384K | Hold |
28,189
| – | – | ﹤0.01% | 1998 |
|
|
2013
Q3 | $313K | Hold |
28,189
| – | – | ﹤0.01% | 2075 |
|
|
2013
Q2 | $232K | Buy |
+28,189
| New | +$237K | ﹤0.01% | 2246 |
|
Other funds holding RGEN
BCM
Metropolitan Life Insurance Company (MetLife)'s RGEN Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Repligen (RGEN) in Q1 2022, closing a stake of 11,668 shares — an estimated $3.09M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in RGEN in Q2 2013 and held it in 35 quarters. The position peaked at $3.42M in Q3 2021. 451 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 11,668 Repligen shares in Q1 2022, an estimated $3.09M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Repligen in Q2 2013 and held it in 35 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Repligen position peaked at $3.42M in Q3 2021.
- 451 funds tracked by Wall St. Rank held Repligen as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.